The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Homology modeling in drug discovery: Overview, current applications, and future perspectives
Abstract
Homology modeling is one of the computational structure prediction methods that are used to determine protein 3D structure from its amino acid sequence. It is considered to be the most accurate of the computational structure prediction methods. It consists of multiple steps that are straightforward and easy to apply. There are many tools and servers that are used for homology modeling. There is no single modeling program or server which is superior in every aspect to others. Since the functionality of the model depends on the quality of the generated protein 3D structure, maximizing the quality of homology modeling is crucial. Homology modeling has many applications in the drug discovery process. Since drugs interact with receptors that consist mainly of proteins, protein 3D structure determination, and thus homology modeling is important in drug discovery. Accordingly, there has been the clarification of protein interactions using 3D structures of proteins that are built with homology modeling. This contributes to the identification of novel drug candidates. Homology modeling plays an important role in making drug discovery faster, easier, cheaper, and more practical. As new modeling methods and combinations are introduced, the scope of its applications widens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
MUSCLE: multiple sequence alignment with high accuracy and high throughput
Edgar, R. C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh340 · Cited by 44,662
Clustal W and Clustal X version 2.0
Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., et al. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm404 · Cited by 28,358
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
The Phyre2 web portal for protein modeling, prediction and analysis
Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N., & Sternberg, M. J. E. (2015) · Nature Protocols · doi:10.1038/nprot.2015.053 · Cited by 9,652
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
Arnold, K., Bordoli, L., Kopp, J., & Schwede, T. (2006) · Bioinformatics · doi:10.1093/bioinformatics/bti770 · Cited by 6,988
T-coffee: a novel method for fast and accurate multiple sequence alignment 1 1Edited by J. Thornton
Notredame, C., Higgins, D. G., & Heringa, J. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4042 · Cited by 6,852
Wiederstein, M., & Sippl, M. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm290 · Cited by 5,909
Cited by
Molecular Docking: Shifting Paradigms in Drug Discovery
Pinzi, L., & Rastelli, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184331 · Cited by 2,344
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“Thus, a technique like homology modeling has been developed to overcome this hindrance [297].”
MethodAlphaFold2 and its applications in the fields of biology and medicine
Yang, Z., Zeng, X., Zhao, Y., & Chen, R. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01381-z · Cited by 577
Drug Design by Pharmacophore and Virtual Screening Approach
Giordano, D., Biancaniello, C., Argenio, M. A., & Facchiano, A. (2022) · Pharmaceuticals · doi:10.3390/ph15050646 · Cited by 384
Advances in De Novo Drug Design: From Conventional to Machine Learning Methods
Mouchlis, V. D., Afantitis, A., Serra, A., Fratello, M., Papadiamantis, A. G., Aidinis, V., Lynch, I., Greco, D., & Melagraki, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041676 · Cited by 353
Recent advances in green synthesized nanoparticles: from production to application
kazemi, S., Hosseingholian, A., Gohari, S. D., Feirahi, F., Moammeri, F., Mesbahian, G., Moghaddam, Z. S., & Ren, Q. (2023) · Materials Today Sustainability · doi:10.1016/j.mtsust.2023.100500 · Cited by 341
Thermodynamics and Kinetics of Drug-Target Binding by Molecular Simulation
Decherchi, S., & Cavalli, A. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00534 · Cited by 301
Molecular Docking: Principles, Advances, and Its Applications in Drug Discovery
Muhammed, M. T., & Aki-Yalcin, E. (2024) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220922103109 · Cited by 267
Self-citationEngineering cytochrome P450 enzyme systems for biomedical and biotechnological applications
Li, Z., Jiang, Y., Guengerich, F. P., Ma, L., Li, S., & Zhang, W. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49939-x · Cited by 260
Rational Design in Photopharmacology with Molecular Photoswitches
Kobauri, P., Dekker, F. J., Szymanski, W., & Feringa, B. L. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202300681 · Cited by 255
Thera-SAbDab: the therapeutic structural antibody database
Raybould, M. I. J., Marks, C., Lewis, A. P., Shi, J., Bujotzek, A., Taddese, B., & Deane, C. M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz827 · Cited by 199
“It can also assist subsequent development and optimization, as homology models of mutants derived from a known structure are in general more accurate than those for which no close structural partner is available (14).”
BackgroundArtificial Intelligence and the Future of Diagnostic and Therapeutic Radiopharmaceutical Development
Ataeinia, B., & Heidari, P. (2021) · PET Clinics · doi:10.1016/j.cpet.2021.06.008 · Cited by 31
Tse, E. G., Aithani, L., Anderson, M., Cardoso-Silva, J., Cincilla, G., Conduit, G. J., Galushka, M., Guan, D., Hallyburton, I., Irwin, B. W. J., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00313 · Cited by 18
(2022) · doi:10.1002/pro.4557 · Cited by 12
eEF2K Inhibitor Design: The Progression of Exemplary Structure-Based Drug Design
Klupt, K. A., & Jia, Z. (2023) · Molecules · doi:10.3390/molecules28031095 · Cited by 11
Assessing the binding properties of CASP14 targets and models
Egbert, M., Ghani, U., Ashizawa, R., Kotelnikov, S., Nguyen, T., Desta, I., Hashemi, N., Padhorny, D., Kozakov, D., & Vajda, S. (2021) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.26209 · Cited by 10
Platzer, G., Ptaszek, A. L., Böttcher, J., Fuchs, J. E., Geist, L., Braun, D., McConnell, D. B., Konrat, R., Sánchez‐Murcia, P. A., & Mayer, M. (2024) · ChemPhysChem · doi:10.1002/cphc.202300636 · Cited by 8
Metadata
- Authors
- Muhammed, M. T., & Aki‐Yalcin, E.
- Venue
- Chemical Biology & Drug Design
- Publisher
- Wiley
- Published
- 2018-10-08
- Volume
- 93
- Issue
- 1
- Pages
- 12-20
- ISSN
- 1747-0277 (ISSN-L)
- 1747-0285
- OpenAlex
- W2892083369
- Cited by
- 358
- References
- 75
- FWCI
- 8.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.